Company Filing History:
Years Active: 2013-2016
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Stuart Schoenherr:
Title: Innovator Stuart Schoenherr: Revolutionizing Oral Magnesium Dosage Forms.
Introduction:
Stuart Schoenherr, a talented inventor hailing from Beeville, TX, has made significant contributions to the field of pharmaceuticals through his innovative approach to controlled-release magnesium oral dosage forms. With an impressive portfolio of four patents, Schoenherr is a leading figure in the realm of drug delivery technologies.
Latest Patents:
Schoenherr's latest patents focus on high-loading, controlled-release magnesium oral dosage forms and the methods for their production and utilization. These dosage forms contain a high concentration of magnesium salts, such as magnesium lactate, and are designed to exhibit controlled-release dissolution profiles, ensuring optimal therapeutic benefits for patients suffering from magnesium deficiency.
Career Highlights:
Currently affiliated with Pharmalyte Solutions, LLC, Schoenherr plays a pivotal role in spearheading groundbreaking research and development initiatives aimed at enhancing the effectiveness of oral drug administration. His expertise in formulating controlled-release dosage forms has earned him accolades within the pharmaceutical industry.
Collaborations:
In his innovative journey, Schoenherr has collaborated closely with esteemed colleagues such as Stephen F. Brandon and Feng Zhang. Together, they have worked synergistically to push the boundaries of pharmaceutical innovation and set new standards for oral magnesium supplementation.
Conclusion:
In conclusion, Stuart Schoenherr stands out as a visionary inventor with a passion for revolutionizing drug delivery technologies. His relentless pursuit of excellence and commitment to solving medical challenges through innovative solutions make him a prominent figure in the realm of controlled-release dosage forms. Keep an eye on this trailblazer as he continues to shape the future of pharmaceutical advancements.